Specific allergy and asthma prevention coming to an age: A milestone in children

Affiliations

¹ Upper Airways Research Laboratory and ENT-Department, Ghent University Hospital, Ghent, Belgium; Division of ENT Diseases, CLINTEC, Karolinska Institute, University of Stockholm, Stockholm, Sweden.
² Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland; Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland. Electronic address: akdisac@siaf.uzh.ch.

Editorial

Claus Bachert et al. J Allergy Clin Immunol. 2018 Feb.

. 2018 Feb;141(2):527-528.

doi: 10.1016/j.jaci.2017.08.022. Epub 2017 Sep 18.

¹ Upper Airways Research Laboratory and ENT-Department, Ghent University Hospital, Ghent, Belgium; Division of ENT Diseases, CLINTEC, Karolinska Institute, University of Stockholm, Stockholm, Sweden.
² Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland; Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland. Electronic address: akdisac@siaf.uzh.ch.

No abstract available

Keywords: Allergen immunotherapy; asthma prevention; children; disease-modifying effect; grass tablet.

Comment on

Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy.
Valovirta E, Petersen TH, Piotrowska T, Laursen MK, Andersen JS, Sørensen HF, Klink R; GAP investigators. Valovirta E, et al. J Allergy Clin Immunol. 2018 Feb;141(2):529-538.e13. doi: 10.1016/j.jaci.2017.06.014. Epub 2017 Jul 6. J Allergy Clin Immunol. 2018. PMID: 28689794 Clinical Trial.